Overview

Dosing of LT4 in Older Individuals

Status:
Recruiting
Trial end date:
2028-04-01
Target enrollment:
Participant gender:
Summary
Our overall goal is to determine the clinical consequences of allowing greater flexibility in LT4 dosing in older individuals who take LT4.
Phase:
Phase 4
Details
Lead Sponsor:
University of Pennsylvania
Collaborator:
National Institute on Aging (NIA)